NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.
The standard of care for managing patients with gastrointestinal stromal tumors (GISTs) rapidly changed after the introduction of effective molecularly targeted therapies involving tyrosine kinase inhibitors (TKIs), such as imatinib mesylate and sunitinib malate. A better understanding of the molecular characteristics of GISTs have improved the diagnostic accuracy and led to the discovery of novel immunomarkers and new mechanisms of resistance to TKI therapy, which in turn have resulted in the development of novel treatment strategies. To address these issues, the NCCN organized a task force consisting of a multidisciplinary panel of experts in the fields of medical oncology, surgical oncology, molecular diagnostics, and pathology to discuss the recent advances, identify areas of future research, and recommend an optimal approach to care for patients with GIST at all stages of disease. The task force met for the first time in October 2003 and again in December 2006 and October 2009. This supplement describes the recent developments in the field of GIST as discussed at the October 2009 meeting.
Demetri
George D
GD
Ludwig Center at Dana-Farber/Harvard Cancer Center, USA.
von Mehren
Margaret
M
Antonescu
Cristina R
CR
DeMatteo
Ronald P
RP
Ganjoo
Kristen N
KN
Maki
Robert G
RG
Pisters
Peter W T
PW
Raut
Chandrajit P
CP
Riedel
Richard F
RF
Schuetze
Scott
S
Sundar
Hema M
HM
Trent
Jonathan C
JC
Wayne
Jeffrey D
JD
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001549:Benzamides; D014408:Biomarkers, Tumor; D004252:DNA Mutational Analysis; D003952:Diagnostic Imaging; D046152:Gastrointestinal Stromal Tumors / Q000473:pathology* / Q000628:therapy*; D020869:Gene Expression Profiling; D006801:Humans; D000068877:Imatinib Mesylate; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011379:Prognosis; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011758:Pyrroles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000077210:Sunitinib
D000970:Antineoplastic Agents; D001549:Benzamides; D014408:Biomarkers, Tumor; D007211:Indoles; D010879:Piperazines; D011743:Pyrimidines; D011758:Pyrroles; D000068877:Imatinib Mesylate; D000077210:Sunitinib
N Engl J Med. 2001 Apr 5;344(14):1052-6
11287975
J Surg Oncol. 2008 Jul 1;98(1):27-33
18452195
Surg Endosc. 2007 Apr;21(4):574-8
17103278
Oncogene. 2008 Sep 18;27(42):5624-34
18521081
Am J Surg Pathol. 2008 Jun;32(6):867-73
18408593
Lancet. 2004 Sep 25-Oct 1;364(9440):1127-34
15451219
Am J Pathol. 2003 Aug;163(2):691-700
12875988
Hum Pathol. 2006 Dec;37(12):1527-35
16996566
Clin Cancer Res. 2008 May 15;14(10):3204-15
18483389
Cancer Res. 2007 Oct 1;67(19):9084-8
17909012
Hematol Oncol Clin North Am. 2009 Feb;23(1):129-37, ix
19248976
Leuk Lymphoma. 2009 Nov;50(11):1882-4
19883316
Histopathology. 2005 May;46(5):522-31
15842634
J Clin Oncol. 2002 Sep 15;20(18):3898-905
12228211
Semin Diagn Pathol. 2006 May;23(2):63-9
17193819
Cell Cycle. 2008 Oct;7(19):2949-55
18818517
Eur J Cancer. 1999 Dec;35(13):1773-82
10673991
Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1237-9
15489588
Am J Surg Pathol. 2005 Oct;29(10):1373-81
16160481
Clin Genitourin Cancer. 2009 Jan;7(1):11-9
19213662
Am J Surg Pathol. 2008 Feb;32(2):210-8
18223323
Pathology. 2008 Jan;40(1):9-12
18038309
J Clin Oncol. 2009 Jan 20;27(3):439-45
19064982
N Engl J Med. 2006 Aug 10;355(6):628; author reply 628-9
16903020
Ann Surg Oncol. 2010 Feb;17(2):407-15
19898902
Gastrointest Endosc. 2003 Jul;58(1):80-8
12838226
Oncogene. 2001 Aug 16;20(36):5054-8
11526490
J Clin Oncol. 2008 Nov 20;26(33):5352-9
18955458
Cancer. 2008 Feb 1;112(3):608-15
18076015
Am J Surg Pathol. 2007 Jan;31(1):113-20
17197927
Genes Chromosomes Cancer. 2008 Oct;47(10):853-9
18615679
Eur J Cancer. 2003 Sep;39(14):2006-11
12957454
Am J Surg. 2008 Sep;196(3):425-9
18466871
Appl Immunohistochem Mol Morphol. 2006 Dec;14(4):390-6
17122634
Eur J Cancer. 2006 May;42(8):1093-103
16624552
Cancer Res. 2004 Sep 1;64(17):5913-9
15342366
Curr Oncol Rep. 2005 Jul;7(4):307-11
15946591
J Clin Oncol. 2010 Mar 1;28(7):1247-53
20124181
Ann Surg Oncol. 2006 Dec;13(12):1596-603
16957966
J Pathol. 2008 Sep;216(1):64-74
18623623
Mol Oncol. 2008 Aug;2(2):161-3
19383335
Mod Pathol. 2000 Oct;13(10):1134-42
11048809
Cancer. 2003 Dec 15;98(12):2693-9
14669291
J Clin Oncol. 2003 Dec 1;21(23):4342-9
14645423
J Intern Med. 2009 Jul;266(1):43-52
19522824
Eur J Surg Oncol. 2009 Aug;35(8):787-92
19185444
Ann Oncol. 2010 Feb;21(2):403-408
19628568
Gastric Cancer. 2005;8(3):135-6
16086114
Cancer Res. 2001 Nov 15;61(22):8118-21
11719439
Science. 2009 Aug 28;325(5944):1139-42
19628817
Lancet. 2006 Oct 14;368(9544):1329-38
17046465
Am J Surg Pathol. 2008 May;32(5):738-43
18360281
AJR Am J Roentgenol. 2007 Dec;189(6):W324-30
18029844
Nat Med. 2006 Aug;12(8):908-16
16862153
Semin Diagn Pathol. 2006 May;23(2):70-83
17193820
Clin Cancer Res. 2004 May 15;10(10):3282-90
15161681
Clin Cancer Res. 2009 Oct 1;15(19):6232-40
19789325
Am J Surg Pathol. 2006 Apr;30(4):477-89
16625094
Histopathology. 1999 May;34(5):416-24
10231416
Lab Invest. 2004 Jul;84(7):874-83
15146165
N Engl J Med. 2008 Jan 3;358(1):95-7
18172185
J Clin Oncol. 2005 Aug 10;23(23):5357-64
15928335
Blood. 2000 Aug 1;96(3):925-32
10910906
Int J Cancer. 2005 Nov 1;117(2):289-93
15900576
Eur J Cancer. 2002 Sep;38 Suppl 5:S60-5
12528774
Am J Surg Pathol. 2009 Sep;33(9):1401-8
19606013
Clin Cancer Res. 2008 Sep 15;14(18):5749-58
18794084
J Surg Oncol. 2009 Jan 1;99(1):42-7
18942073
Br J Cancer. 2003 Aug 4;89(3):460-4
12888812
Am J Surg Pathol. 2009 Mar;33(3):437-46
19011564
J Clin Oncol. 2006 Oct 10;24(29):4764-74
16954519
Am J Surg. 2003 Dec;186(6):665-9
14672776
Eur J Cancer. 2005 Dec;41(18):2868-72
16293410
J Clin Oncol. 2007 May 1;25(13):1760-4
17470866
Nat Rev Clin Oncol. 2009 Apr;6(4):219-28
19333228
Eur J Cancer. 2005 Aug;41(12):1751-7
16098458
Clin Cancer Res. 2006 Mar 15;12(6):1743-9
16551858
Cancer. 1995 Jan 1;75(1 Suppl):154-70
8000994
Science. 2003 Jan 31;299(5607):708-10
12522257
Mod Pathol. 2006 Nov;19(11):1480-6
16892012
J Clin Oncol. 2009 Aug 20;27(24):3969-74
19620483
APMIS. 2006 Mar;114(3):192-200
16643186
J Clin Oncol. 2008 Feb 1;26(4):620-5
18235121
J Clin Oncol. 2007 May 1;25(13):1753-9
17470865
Cancer. 2010 Jan 1;116(1):184-92
19885836
Cancer. 2005 Feb 15;103(4):821-9
15648083
Oncologist. 2002;7(6):531-8
12490740
N Engl J Med. 2006 May 11;354(19):2006-13
16687713
Clin Cancer Res. 2009 Sep 15;15(18):5910-6
19723647
Virchows Arch. 2001 Jan;438(1):1-12
11213830
Gastroenterology. 2005 Feb;128(2):270-9
15685537
Clin Cancer Res. 2007 Jan 1;13(1):170-81
17200352
Ann Surg Oncol. 2009 Apr;16(4):910-9
18953611
Ann Surg Oncol. 2007 Jan;14(1):14-24
17072676
Eur J Cancer. 2009 Sep;45(13):2293-7
19467857
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8387-92
18550829
Int J Cancer. 2005 Nov 1;117(2):316-25
15900603
Oncogene. 2004 Oct 14;23(47):7780-90
15326474
Ann Oncol. 2009 May;20(5):807-15
19150949
Semin Oncol. 2009 Aug;36(4):302-11
19664491
J Clin Oncol. 2009 Jul 1;27(19):3141-7
19451435
Surg Endosc. 2007 Jun;21(6):875-8
17180273
Clin Cancer Res. 2003 Aug 15;9(9):3329-37
12960119
Haematologica. 2006 Jun;91(6 Suppl):ECR27
16785130
Am J Pathol. 2004 Jul;165(1):107-13
15215166
Histopathology. 2008 Sep;53(3):245-66
18312355
Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):205-20
16082245
Cancer Invest. 2002;20(5-6):605-12
12197215
Hematol Oncol Clin North Am. 2009 Feb;23(1):1-13, vii
19248967
J Pediatr Hematol Oncol. 2005 Apr;27(4):179-87
15838387
Lancet Oncol. 2009 Nov;10(11):1045-52
19793678
Clin Cancer Res. 2009 Nov 15;15(22):7045-52
19903787
Pediatr Blood Cancer. 2009 Jul;52(7):767-71
19326424
Cancer. 1978 Sep;42(3):1375-84
81101
Cancer. 2006 Nov 1;107(9):2237-44
16998931
Arch Surg. 2006 Jun;141(6):537-43; discussion 543-4
16785353
Cancer. 2009 Aug 1;115(15):3571-80
19536893
J Pathol. 2004 Apr;202(4):430-8
15095270
Clin Cancer Res. 2004 May 1;10(9):3076-81
15131046
Clin Cancer Res. 2009 Nov 15;15(22):6862-70
19861442
Lancet. 2002 Apr 13;359(9314):1301-7
11965276
Lab Invest. 2006 Jan;86(1):94-100
16258521
J Surg Oncol. 2006 Mar 15;93(4):304-11
16496358
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1542-7
19164557
Cancer Res. 2006 Jan 1;66(1):473-81
16397263
Clin Cancer Res. 2008 Jul 15;14(14):4550-5
18628470
Ann Surg. 2007 Mar;245(3):347-52
17435539
Hum Pathol. 2002 May;33(5):459-65
12094370
Eur J Cancer. 2004 Mar;40(5):689-95
15010069
Ann Surg. 2000 Jan;231(1):51-8
10636102
Blood. 2009 May 28;113(22):5401-11
19349618
Nat Rev Gastroenterol Hepatol. 2009 Jun;6(6):363-71
19365407
Ann Surg. 1987 Dec;206(6):706-10
3689007
Cancer. 2006 Oct 1;107(7):1617-23
16955508
Oncologist. 2004;9(3):271-81
15169982
J Clin Oncol. 2008 Nov 20;26(33):5360-7
18955451
Br J Cancer. 2008 May 20;98(10):1633-40
18475296
Cancer Res. 2004 Aug 1;64(15):5127-31
15289315
Arch Pathol Lab Med. 2006 Oct;130(10):1466-78
17090188
Lancet. 2009 Mar 28;373(9669):1097-104
19303137
Clin Cancer Res. 2005 Jun 1;11(11):4182-90
15930355
Lancet. 2007 Dec 15;370(9604):2011-9
18083403
J Clin Oncol. 2009 Jan 10;27(2):312-3
19064960
Eur J Cancer. 2007 Jan;43(1):144-8
17055254
Int J Cancer. 2008 Feb 1;122(3):711-8
17943734
Cancer. 2005 Nov 1;104(9):1781-8
16136600
J Am Coll Surg. 2006 Apr;202(4):623-9
16571433
Cell Cycle. 2004 Dec;3(12):1502-5
15611623
Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6073-8
17062683
Ann Surg. 1993 Jan;217(1):72-7
8424704
J Clin Oncol. 2006 May 20;24(15):2325-31
16710031
Ann Surg. 2006 Jun;243(6):738-45; discussion 745-7
16772777
Ann Oncol. 2008 Jul;19(7):1293-1298
18372285
Nat Med. 1996 May;2(5):561-6
8616716
Cancer Invest. 2005;23(3):274-80
15945512
Oncol Rep. 2009 Jun;21(6):1359-66
19424610
Gastroenterology. 2003 Sep;125(3):660-7
12949711
Radiology. 2005 Jun;235(3):892-8
15833985
Am J Pathol. 2002 May;160(5):1567-72
12000708
J Clin Oncol. 2008 Feb 1;26(4):626-32
18235122
J Clin Oncol. 2005 Sep 1;23(25):6190-8
16135486
Clin Cancer Res. 2002 Oct;8(10):3034-8
12374669
Gastroenterology. 2006 May;130(6):1573-81
16697720
Eur J Cancer. 2009 Jul;45(11):1959-68
19282169
Eur J Hum Genet. 2008 Jan;16(1):79-88
17667967
Am J Surg Pathol. 2004 Jul;28(7):889-94
15223958
Mod Pathol. 2008 Apr;21(4):476-84
18246046
J Gastrointestin Liver Dis. 2009 Jun;18(2):177-80
19565047
Ann Surg. 1992 Jan;215(1):68-77
1731651
Arch Surg. 2008 Jun;143(6):587-90; discussion 591
18559753
Lancet. 2001 Oct 27;358(9291):1421-3
11705489
Mod Pathol. 2000 May;13(5):577-85
10824931
Cancer. 2006 Dec 15;107(12):2833-41
17096432
Ann Intern Med. 2006 Nov 7;145(9):660-4
17088579
J Pharmacol Exp Ther. 2000 Oct;295(1):139-45
10991971
Surgery. 2006 Apr;139(4):484-92
16627057
N Engl J Med. 2002 Aug 15;347(7):472-80
12181401
Acta Oncol. 2009;48(1):9-17
18752081
Am J Gastroenterol. 2005 Jan;100(1):162-8
15654796
N Engl J Med. 2005 Aug 4;353(5):487-97
16079372
Am J Surg Pathol. 2005 Jan;29(1):52-68
15613856
Mod Pathol. 2003 Dec;16(12):1257-64
14681327
Cancer Biol Ther. 2005 Jul;4(7):747-52
15970668
Ann Surg. 2007 Mar;245(3):341-6
17435538
Int J Cancer. 2009 Dec 15;125(12):2991-4
19672856
J Clin Oncol. 2007 Mar 20;25(9):1107-13
17369574
J Gastroenterol. 2005 Aug;40(8):775-80
16143881
Histol Histopathol. 2000 Oct;15(4):1293-301
11005253